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Abstract
Using a computer-assisted image anal-
yser, an immunohistochemical quanti-
fication method of substance P-like
immunoreactivity (SPLI) in laminae I +
II of spinal dorsal horn was established
and applied to 13 patients with multiple
system atrophy (MSA) with no distur-
bance of pain sensation, including olivo-
ponto-cerebellar atrophy and striato-
nigral degeneration, and 13 neuro-
logically normal controls. To investigate
whether alteration of SPLI is related to
an autonomic disorder, myelinated fibre
counts of the fourth thoracic ventral
roots were performed. Eleven of 13 MSA
patients showed a significant decrease in
small and large myelinated fibres, and
were diagnosed with definite Shy-Drager
syndrome (SDS), with the exception of
two who had no apparent history of
autonomic dysfunction. SPLIs in lami-
nae I + II in 10 of these 11 patients, when
adjusted for age, were significantly
decreased at both levels of the fourth
thoracic and third lumbar spinal seg-
ments. The results suggest the disorder
of SP-containing synapses of primary
afferent neurons and/or those of inter-
neurons in SDS.
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The neuropeptide substance P(SP) has been
suggested as a nociceptive neurotransmitter2
or a neuromodulator34 of primary afferent
neurons. A marked depletion of SP-like
immunoreactivity (SPLI) in the superficial
laminae of the dorsal horn was reported in
several conditions: dorsal rhizotomy,5 cap-
saicin treatment67 and peripheral nerve
lesions.89 Most of the SP in the superficial
dorsal horn may be contained in the central
terminals of unmyelinated C-fibres of small
diameter cells in the dorsal root ganglia.
Nociceptive information is relayed to both
lamina I and the outer layer of lamina II,"1
and to a lesser extent to the inner layer of
lamina II.' This localisation pattern of SP has
been supported by a number of immunohisto-
chemical studies showing the strongest im-
munoreactions in lamina I and dorsal parts of
lamina 1.""1213 On the grounds that SP
antigenicity can be retained in formaldehyde-
fixed and paraffin-embedded specimens for
many years,'4 a quantitative immunohisto-
chemistry for SP in the laminae I + II can be
available for evaluation of synapses containing
SP of both intrinsic and extrinsic origin.
Shy-Drager syndrome (SDS)15 is character-
ised by the autonomic failure, such as ortho-
static hypotension, urinary incontinence,
inability to perspire, and sexual impotence,
attributable to loss of preganglionic cells in
the intermediolateral nuclei (IML).'6 Since
this syndrome frequently shows widespread
neuronal degeneration in the striatonigral sys-
tem, locus ceruleus, pontine nuclei, inferior
olive and cerebellar cortex,'7 it is therefore
classified as multiple system atrophy (MSA).'8
Several morphometric studies on thoracic
ventral roots of the patients with SDS have
shown that small myelinated fibres decrease
significantly in number as an explanation of
autonomic dysfunction.'920 Although unmye-
linated fibres compose a large part of the
autonomic pathway, only comparatively few
studies have been done concerning the affec-
tion of peripheral unmyelinated fibres in
SDS.21 22
In this study, patients with MSA were first
divided into two classes either with or without
autonomic disorders by their clinical and
pathological findings, as well as morphometric
features of the thoracic ventral roots. Sec-
ondly, after evaluating the effects of necropsy
delay on SP immunostain, an optimal condi-
tion for the SP immunohistochemistry and a
quantification method for image analysis were
established and then applied to those patients
and controls.
Materials and methods
Patients
Necropsies were carried out on 13 patients with
MSA, all with olivo-ponto-cerebellar atrophy
(OPCA), 10 with striato-nigral degeneration
(SND) (table 1), and 13 age matched controls
without neurological disorder (table 2). There
was no definite loss of pain sensation in any of
the patients. Maximal intervals between death
and beginning of necropsy were 11 and 14
hours. After a maximal length of 24 or 25 days
fixation by 10% neutralised formalin in each
group, the sixth cervical (C6), fourth thoracic
(T4) and third lumbar (L3) segments of the
spinal cord were excised, embedded in paraffin
and cut into 7,m transverse sections. Serial
sections were processed for HE, Kluver-
Barrera's (KB) stains and SP immunohisto-
chemistry.
The sampling and processing of morpho-
metry of the T4 ventral roots were performed
according to the Low and Dyck method.23 The
transverse fascicular area and the diameter
distribution of myelinated fibres per root were
measured in photographs magnified to x 100
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Table 1 Patients with multiple system atrophy
Duration Autonomic sign Pathology
Case Age Sex PI Fix L FT AD OH VRD AH OPCA SND
M 1 44 F 7 23 3 1, 6 - + ND + +
M 2 51 F 10 14 9 4, 0 + + ND + +
M 3 52 F 4-5 18 13 ND + ND + +
M 4 57 M 5-5 20 4 3, 7 + + ND + -a
M 5 59 F 4 21 8 6, 2 + + + + +
M 6 61 M 8 24 5 5, 0 + + + + +
M 7 61 F 11 18 7 - - - + -
M 8 62 F 3 19 6 3, 9 + + ND + +
M 9 63 F 3 10 7 - - - + -
M10 64 M 7-5 14 6 4, 0 + + + + +
Mul 68 F 9 19 8 5,10 + + ND + +
M12 72 M 10 21 5 2, 0 ND + + + +
M13 73 F 5 ND 6 5, 6 ND + + + +
Mean 60-3 6-7 18-4 69 4, 2
PI: postmortem interval (hours); Fix L: fixation length (days); FT: full tern (years); AD: duration of autonomic dysfunction (years, months); OH: orthostatic
hypotension; VRD: vesicorectal disturbance including dysuria, urinary incontinence and constipation; AH: anhidrosis; Pathology: complicated pathological
diagnosis; OPCA: olivo-ponto-cerebellar atrophy; SND: striato-nigral degeneration; ND: not described in necropsy record; a: mild gliosis without neuronal loss.
Table 2 Age-matched controls
Case Age Sex Cause of death PI Fix L
C 1 42 M Acute renal failure 5-5 21
C 2 49 F Cardiac 3 16
C 3 52 M Pulmonary bleeding 2 16
C 4 53 F Headtrauma 12 18
C 5 58 M Sudden death 2-5 19
C 6 61 M Subarachnoid haemorrhage 10 16
C 7 65 F Subarachnoid haemorrhage 14 17
C 8 69 F Suicide 4 25
C 9 71 M Acute abdomen 5 24
CIO 71 F Subarachnoid haemorrhage 3 22
C1l 73 M Acute renal failure 2 18
C12 78 F Head trauma 4-5 20
C13 82 F Cardiac 13 5 17
Mean 63-4 6-2 19 2
PI: postmortem interval (hours); Fix L: fixation length (days).
and x 1000, respectively. According to the
diameter distributions in the control study, the
division point between large and small myelin-
ated fibres was determined at 6-16 gm.
Adult rats (Sprague-Dawley; 230-250 g;
n = 47) were decapitated under deep anaes-
thesia with diethyl ether and were kept at 4°C.
At six different intervals (0, 2, 4, 8, 16 and 24
hours) the lumbar spinal cord segments were
excised and immediately immersed in 10%
neutralised formalin for two days at room
temperature. The fifth lumbar segments were
dissected and processed in the same manner as
the human materials.
Polyclonal anti-SP antibody was raised in a
New Zealand white rabbit against synthetic SP
(Peptide Institute, Osaka, Japan), which was
conjugated to bovine serum albumin (BSA)
with carbodiimide as a coupling agent accord-
ing to Chopra.24 An anti-SP titre was raised to
1:12 800 dilution against 70 ng synthetic SP by
dot blotting immunoassay (Promega Biotec,
Madison). Antiserum specificity was tested
with both preabsorbed serum and affinity-
purified antibody. Immunostaining was abol-
ished by the preabsorption of the antibody
with synthetic SP (5 jug/1 ml SP antiserum).
Affinity-purified antibody, which was prepared
from the whole SP antiserum by the method of
Talian et al,25 differentiated the SP in the dorsal
horn of the spinal cord less strongly than the
whole SP antiserum while distribution of the
immunostained vesicles was similar to each
other. Control sections stained with pre-
immune serum showed no positive stain.
Immunostaining was performed using the
whole SP antiserum.
After removing the paraffin, the tissue sec-
tions were pretreated with 0 3% H2O, for 30
minutes to reduce non-specific staining by
endogenous peroxidases. The unlabelled
antibodies biotin-streptavidin method
(Stravigen, BioGenix Laboratories, Dublin,
CA) was applied. After washing with PB (0 IM
phosphate, 0-5M NaCl, pH 7.3), the sections
were incubated for two days at 4°C with diluted
anti-SP containing 0-2% Triton X-100. After
washing with PB, the tissue sections were
exposed with biotinylated anti-rabbit IgG
antibodies and streptavidin-horseradish
peroxidase complex for three hours each, at
room temperature. Diaminobenzidine tetra-
hydrochloride (DAB) containing H,O, was
used to develop the colour.
To obtain a high contrast between SP-
specific immunoreactive products and the
surrounding background in light microscopic
image analysis, optimal immunohistochemical
conditions were examined according to the
method proposed by Gross.26 As major effective
variables, antibody dilution (1/8000-1/250),
DAB concentration (0 002-0 05%), H,O. con-
centration (0-0005-O-05%) and reaction time in
DAB (1-10 min) were altered independently.
Consecutive serial sections of the L3 segment
of a control (C 1i) was used for this purpose. To
avoid any misinterpretation during image
analysis, no counterstain was done.
A computer-assisted image analyser (IBAS
II, Kontron) was used for quantification of SP-
specific immunoreactive products. After ap-
propriately setting the detection threshold, the
total area occupied by these products (im-
munostained area) in the whole area of laminae
I+ II (reference area) was extracted from the
background. The percentage of the immuno-
stained area versus the reference area was
calculated (%Ia) and those of the bilateral
dorsal horn were averaged. Because the
borderline between lamina II and III could not
be directly ensured on the immunohisto-
chemical preparation without counter stain,
the reference area was determined from its
neighbouring KB preparation as follows: a
digitised image of the dorsal horn, which was
obtained from the KB preparation at each level
of the spinal segments through a videomicro-
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Figure 1 Schematic
illustrations in set of K)
reference area at the level
of the L3 cord segment.
Reference area necessary - '-¾
to immunohistochemical
quantification (A) was
obtained by transforming /./ w as
the contour of laminae I + -** '-.;S'S ,
II circumscribed by the toj A,
of arrow heads in the
neighbouring section with
KB stain (B). The areas
occupied by large vessels
andfibre bundles were
excludedfrom the object. -
Bars = 300 pm.
Figure 2 Numbers of
small (A) and large (B)
myelinatedfibres per T4
ventral root of controls
(@), SDS (C1) patients
and other patients ( A ).
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Figure 3 Transverse
sections and diameter
distributions of the T4
ventral roots of a control
(C4) (A, C) and a SDS
patient (M4) (B, D).
Bars = 20 pm.
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scope hardware, was stored in one image
memory (KB-image memory) at 120 x mag-
nification. The image of the identical site of SP
immunohistochemical preparation was stored
in another image memory (SP-image memory)
at the same magnification. On theTV image on-
line with KB-image memory, the contour of
laminae I+II was drawn as an overlay image
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Figure 4 Effect ofvarious
postmortem intervals on
SPLI in rats.
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Table 3 Numbers of myelinatedfibres of the T4 ventral root and SPLI in laminae
I+II
Number of myelinated fibres SPLI (%Ia)
SMF LMF C6 T4 L3
C 1 5183 1720 5-17 447 4-89
C 2 6154 1834 790 3-81 4-52
C 3 5649 1547 541 4-06 6-73
C 4 4421 1426 645 5-14 6-14
C 5 5213 1569 352 3-27 3-75
C 6 4207 1505 408 5-45 589
C 7 3917 1432 391 4-31 304
C 8 4416 1610 422 2 16 390
C 9 5815 1516 226 2-73 2-39
CIO 3986 1205 1-86 2-49 2-04
C1l 3618 1248 2-14 1 52 5-08
C12 4021 1293 2-10 2 21 2-41
C13 4163 1488 1-47 0 98 1-76
Mean (SD) 4674 (794) 1492 (171) 3-88 (1 88) 3 23 (1 34) 4 04 (1
M 1 1627* 490* 0.97* 0.24* 0.48*
M 2 984* 583* 2.84* 0.46* 0.86*
M 3 2103* 1082* 418 3-01 3.21*
M 4 1983* 725* 3 74 1.21* 2.19*
M 5 528* 279* 0.79* 1.52* 1 17*
M 6 1763* 694* 0-24* 0.59* 0-62*
M 7 4826 1542 2-08 4 61 3-68
M 8 1537* 429* 0.74* 0.11* 0.76*
M 9 4110 1250 4-63 2 83 5-54
M1O 1285* 1071* 2-27 1.56* 2.39*
M11 2010* 754* 3 62 0.18* 2 30
M12 1951* 793* 5 31 0.46* 0.40*
M13 1748* 671* 1-52 0.07* 0.58*
Mean (SD) 2035 (1130) 797 (339) 2.34s (1-59s) 068S (0.56s) 1.25s (0
Data on the T4 ventral root are expressed in number per root. SMF = small myelinated f
LMF = large myelinated fibres.
*Statistically significant (p < 0-05); S: Mean (SD) of SDS patients.
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Figure 5 Effects of SP immunohistochemical parameters. A: antiserum dilution.
specific reaction deposits reached maximal level at 1/2000 or 1/1000. Below 1/500,
SP showed a rapid increase with non-specific background staining. B: DAB
concentration. DAB concentration was increasedfrom 0-002 to 0-05% by holding
concentration constant at either 0-003 or 0 009%. With 0 003% H20,, the specific
staining was maximal at 0-02% DAB. Beyond the 0-02% DAB, this H202
concentration was too low to allow an enzymatic reaction. In the presence of 0 009!,
H202, at 0 01 to 0 05% DAB, the specific staining was maximal but not saturated.
H202 concentration. H202 concentration was altered while DAB concentration was
constant at two different levels. With 0 01% DAB, the specific staining showed a li
increase to reach a maximum at 0 003 to 0 01% H202. In more than 0-03% H202,,
area increased in a rapidly acceleratingfashion due to the measurement of non-speci
backgroundfeature. D: reaction time in DAB. Over the first phase, anti-SP 1/2001
have a rapid increase in detected specific reaction products. After a short plateau pA
which starts at three minutes and ends at five minutes, the immunostained area incre
rapidly due to non-specific staining. A: DAB = 0 01%, H202 = 0003%, reaction
= 4 minutes, B, C: antibody dilution = 1/2000, reaction time = 4 minutes D: ant
dilution = 1/2000, DAB = 0-01%, H202= 0003%.
(fig 1). According to Rexed,27 the nerve cells of
lamina II in a cat were either round or more
often slightly elongated and the majority were
5-10 x 5-10 gim in size. Those of lamina III
were more varied in size with the largest cell
reaching 15 x 18 pm around. In KB prepara-
tion, the increasing number of fibres in lamina
III contributed to a darker appearance as a
whole than lamina II. This overlay image was
subsequently transferred to the SP-image
memory to fit the reference area. The executive
programme with the above serial procedures
was set up by referring to the second edition.
Results were expressed as the means (SD).
59) Correlations were assessed by Pearson's
product moment correlation test. The dif-
ference in number ofmyelinated fibres between
the patients and controls was analysed by the
Student's t test. The difference of SPLI (%Ia)
was tested by a two-way analysis of variance
(two-way ANOVA). The data were considered
to be statistically significant at p < 0 05.
Results
.-76S) In the controls, the number (per root) of small
myelinated fibres (SMF) ranged from 3618 to
ibres; 6154 [4674 (794)] while that of large myelinated
fibres (LMF) ranged from 1205 to 1834 [1492
(171)] (table 3). Both SMF and LMF showed a
significant decrease in the number with increas-
ing age (SMF: p < 0-05; R = -0 63; Y =
7257-40 8X, LMF: p < 0-05; R =-0-66; Y =
2109-9X7X) (fig 2).003% Of 13 MSA patients, 11 showed a significant
decrease in the number of both SMF (p <
0-01) and LMF (p < 0 01). The decrease was
more prominent in SMF than in LMF (figs 2,
3). The variation in the number among all
patients was from 528 to 4826 [2035 (1130)] in
SMF and from 279 to 1542 [797 (339)] in LMF
(table 3). Because two (Ml, M3) of these 11
0.1 patients did not show any definite autonomic
failure (Ml: no orthostatic hypotension, M3:
vesicorectal disturbance is not specific to auto-
nomic sign), we diagnosed the remaining nine
patients as definite SDS. Two cases without any
decrease in the number of SMF (M7, M9)
showed no autonomic dysfunction.
SPLI in the rat spinal cord was well pre-
served up to at least 24 hours (fig 4). Although
SPLI showed a tendency to increase slightly
with time, there were no significant differences
between each interval. SP-like immunoreactive
10 products of superficial dorsal horn in rats were
smaller in shape and more homogeneous than
in humans.
SP Alterations of SPLI dependent on para-
anti- metric value were shown in fig 5. As expected
V202 from the observations, anti-SP 1/2000, 0-01%1202 DAB, 0-003% H202 and a reaction for 4
minutes are optimal values for the image
C: analysis on the SP immunohistochemical
held preparations.
near Figure 6 showed representative SP im-
the munostaining of the same cases (C4, M4) as in
ific10 fig 2. In the control, SP immunolabelling was
rase seen in abundance in lamina I and the dorsal
eased parts of lamina II(A), and showed various
,ztimeijbody appearances in shape, that is, fine granular,
vesicular and linear varicositous (C). In the
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Figure 6 Representative
SP immunostaining and its
details at higher
magnification in the
superficial dorsal horn. A,
C: a control (C4), B, D:
a patient (M4). Barsfor
A, B = 200 pm, barsfor
C, D = 50 pm.
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Figure 7 Immunostained
area (%) of controls
(*), SDS patients (EO)
and other patients (A ) at
the level of the C6(A),
T4(B) and L3(C) spinal
segments.
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patient, SP-positive products were severely
depleted (B, D).
As shown in table 3, the controls showed
wide variations ofSPLI (% Ia) at three different
levels of spinal cord. There were significant
reductions in SPLI with increasing age at all
three levels (C6: p < 0-05; R =-086; Y =
12 680-14X, T4: p < 0 05; R =-0-78; Y =
898-O009OX, L3: p < 0-05; R =-0-69; Y =
10O12-OlOX( (fig 7). The slopes were not
significantly different between the three levels.
SPLI showed no significant correlation with
sex, postmortem interval and fixation length.
In the patients with SDS, SPLIs (%Ia) were
also varied. The range of %Ia in SDS patients
overlapped with those of the controls for the
most part at the C6 level, and for a lesser part at
the T4 and L3 level. But when adjusted for age
(two way ANOVA), SPLIs in all SDS patients
and one other patient (Ml), with a significant
decrease ofmyelinated fibres, were significantly
decreased at the T4 (p < 005) and L3 (p <
005) levels except for one (Ml 1) at the L level
(fig 7). SPLI of SDS patients did not correlate
statistically with the duration either of the
disease or of the autonomic dysfunction.
Discussion
We performed the morphometric study to
diagnose definite SDS patients. It is generally
assumed that small and large myelinated fibre
counts in the thoracic ventral root are simple
and reliable methods to evaluate the loss of
preganglionic autonomic neurons in IML, and
alpha and gamma motor neurons in the ventral
horn, respectively.
SPLI on the tissue section of autopsied
material alters depending on either the
degradation of SP itself before fixation or
autolysis of the tissue which influences the
immobilisation of SP by fixatives. SP in the
brain was stable for at least 72 hours after death
at room temperature in a biochemical study
using a radioimmunoassay technique.28
Degradation of SP is not considered in our
cases with postmortem intervals of shorter than
16 hours. The degree ofautolysis is different for
each material depending on postmortem hand-
ling, especially necropsy delay, even if the
material is stored in a refrigerator at a constant
temperature. The effects therefore of necropsy
delay on SP immunostain were examined on rat
spinal cords under similar postmortem condi-
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tions as humans and good preservation of SPLI
up to 24 hours was confirmed. Once optimal
immunohistochemical conditions were estab-
lished, it was possible to compare the intensity
of SPLI between each autopsied material.
SP quantitative data on the controls in this
study confirmed the age-related decrease of
SPLI in the superficial dorsal horn of humans.
In view of the age-related decrease in the
number ofnerve cells ofthe first sacral ganglia,29
this decrease of SPLI may be due to an age-
related decrease in the number of SP-nergic
primary afferent neurons rather than the
decrease of SP content per neuron. Emson2"
described the content of SP in normal human
brains as not significantly affected by age. This
disparity is probably due to the difference ofthe
regions studied.
Our study is the first immunohistochemical
report demonstrating the decrease of SP in the
superficial dorsal horn of SDS patients, which
were definitely diagnosed with the morpho-
metry of spinal ventral roots. This finding
agrees with a study by Anand et al,' who
revealed a marked depletion of SP in the spinal
dorsal horn of four MSA patients by radio-
immunoassay. The pain sensation of our
patients, however, was almost spared entirely
as in previous reports.'51819 The most likely
interpretation of the results is that the loss of
SP is not sufficient to affect nociception in a
detectable manner. We also counted the num-
ber of myelinated fibres in the dorsal roots, but
there was no significant decrease in number in
SDS patients (not shown). Unmyelinated C-
fibre cannot be discriminated by this method.
Another plausible explanation is that the
decrease of SP immunostaining in the dorsal
horn is caused by the loss of non-nociceptive
SP-containing visceral afferents. SP is also
known to occur in interneurons of the super-
ficial dorsal horn.2 Moreover, some A delta
sensory fibres contain SP.6 The ratio of SP
content in these three populations has not been
fully examined. We also performed a similar
quantitative study about calcitonin-gene
related peptide (CGRP), a neuropeptide co-
localising with SP in neurons of dorsal root
ganglia,3" but a decrease of CGRP was not
detected in these SDS patients. The decreased
concentration ofSP in the cerebrospinal fluid of
SDS patients may reflect the disorder of SP-
containing primary sensory and/or intraspinal
neurons.32 Further study will be needed to
distinguish between these alternatives.
As for SP in the primary sensory neurons, it
is ofparticular interest that SP immunoreactive
fibres of a sensory nature pass through the
sympathetic ganglion with SPLI varicose net-
work surrounding postganglionic neurons33-36
and SP plays a transmitter role in the sym-
pathetic ganglion.37 These suggest an inter-
action between the autonomic disorder and the
depletion of SP in primary sensory neurons of
SDS patients.
This study has shown that a quantitative
immunohistochemical evaluation of SPLI can
be applied to human material at necropsy and
SPLIs are considerably depleted in the super-
ficial dorsal horn of the patients with SDS.
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